Search Results - Morese, Roberto

  • Showing 1 - 9 results of 9
Refine Results
  1. 1
    Cutaneous Squamous Cell Carcinoma: From Pathophysiology to Novel Therapeutic Approaches

    Cutaneous Squamous Cell Carcinoma: From Pathophysiology to Novel Therapeutic Approaches by Fania, Luca, Didona, Dario, Di Pietro, Francesca Romana, Verkhovskaia, Sofia, Morese, Roberto, Paolino, Giovanni, Donati, Michele, Ricci, Francesca, Coco, Valeria, Ricci, Francesco, Candi, Eleonora, Abeni, Damiano, Dellambra, Elena

    Published in Biomedicines
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Basal Cell Carcinoma: From Pathophysiology to Novel Therapeutic Approaches

    Basal Cell Carcinoma: From Pathophysiology to Novel Therapeutic Approaches by Fania, Luca, Didona, Dario, Morese, Roberto, Campana, Irene, Coco, Valeria, Di Pietro, Francesca Romana, Ricci, Francesca, Pallotta, Sabatino, Candi, Eleonora, Abeni, Damiano, Dellambra, Elena

    Published in Biomedicines
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Weekly carboplatin plus paclitaxel chemotherapy in advanced melanoma patients resistant to anti-PD-1 inhibitors: a retrospective, monocentric experience

    Weekly carboplatin plus paclitaxel chemotherapy in advanced melanoma patients resistant to anti-PD-1 inhibitors: a retrospective, monocentric experience by Di Pietro, Francesca Romana, Marinelli, Daniele, Verkhovskaia, Sofia, Poti, Giulia, Falcone, Rosa, Carbone, Maria Luigia, Morelli, Maria Francesca, Zappalà, Albina Rita, Di Rocco, Zorika Christiana, Morese, Roberto, Piesco, Gabriele, Chesi, Paolo, Marchetti, Paolo, Failla, Cristina Maria, De Galitiis, Federica

    Published in BMC cancer
    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  4. 4
    Case report: Fast disease progression during adjuvant therapy with anti-PD-1 in stage III melanoma patients

    Case report: Fast disease progression during adjuvant therapy with anti-PD-1 in stage III melanoma patients by Di Pietro, Francesca Romana, Verkhovskaia, Sofia, Falcone, Rosa, Poti, Giulia, Carbone, Maria Luigia, Morelli, Maria Francesca, Zappalà, Albina Rita, Morese, Roberto, Di Rocco, Zorika Christiana, Piesco, Gabriele, Chesi, Paolo, Failla, Cristina Maria, Marchetti, Paolo, De Galitiis, Federica

    Published in Frontiers in oncology
    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  5. 5
    Primary Mucosal Melanoma: Clinical Experience from a Single Italian Center

    Primary Mucosal Melanoma: Clinical Experience from a Single Italian Center by Falcone, Rosa, Verkhovskaia, Sofia, Di Pietro, Francesca Romana, Poti, Giulia, Samela, Tonia, Carbone, Maria Luigia, Morelli, Maria Francesca, Zappalà, Albina Rita, di Rocco, Zorika Christiana, Morese, Roberto, Piesco, Gabriele, Marchetti, Paolo, Failla, Cristina Maria, De Galitiis, Federica

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    Integrated care pathways and the hub-and-spoke model for the management of non-melanoma skin cancer: A proposal of the Italian Association of Hospital Dermatologists (ADOI)

    Integrated care pathways and the hub-and-spoke model for the management of non-melanoma skin cancer: A proposal of the Italian Association of Hospital Dermatologists (ADOI) by Fania, Luca, Massone, Cesare, Cusano, Francesco, Fantini, Fabrizio, Dellambra, Elena, Samela, Tonia, Passarelli, Francesca, Morese, Roberto, Tartaglione, Tommaso, Maggiore, Marino, Gentile, Piercarlo, Falchetto Osti, Mattia, Sampogna, Francesca, Pallotta, Sabatino, Abeni, Damiano, Marchetti, Paolo, Naldi, Luigi, ADOI steering group

    Published in Dermatology reports
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    Vitiligo-like leukoderma as an indicator of clinical response to immune checkpoint inhibitors in late-stage melanoma patients

    Vitiligo-like leukoderma as an indicator of clinical response to immune checkpoint inhibitors in late-stage melanoma patients by Verkhovskaia, Sofia, Di Pietro, Francesca Romana, Mastroeni, Simona, Carbone, Maria Luigia, Abeni, Damiano, Morese, Roberto, Morelli, Francesca Maria, D’Atri, Stefania, Marchetti, Paolo, De Galitiis, Federica, Failla, Cristina Maria, Fortes, Cristina

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  8. 8
    Treatment-related side effects and quality of life in cancer patients

    Treatment-related side effects and quality of life in cancer patients by Mazzotti, Eva, Antonini Cappellini, Gian Carlo, Buconovo, Stefania, Morese, Roberto, Scoppola, Alessandro, Sebastiani, Claudia, Marchetti, Paolo

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  9. 9
    Survival of Patients with Metastatic Melanoma Treated with Ipilimumab after PD-1 Inhibitors: A Single-Center Real-World Study

    Survival of Patients with Metastatic Melanoma Treated with Ipilimumab after PD-1 Inhibitors: A Single-Center Real-World Study by Verkhovskaia, Sofia, Falcone, Rosa, Di Pietro, Francesca Romana, Carbone, Maria Luigia, Samela, Tonia, Perez, Marie, Poti, Giulia, Morelli, Maria Francesca, Zappalà, Albina Rita, Di Rocco, Zorika Christiana, Morese, Roberto, Piesco, Gabriele, Chesi, Paolo, Marchetti, Paolo, Abeni, Damiano, Failla, Cristina Maria, De Galitiis, Federica

    Published in Cancers
    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:

Search Tools: